Imunon Inc Stock Price on September 20, 2024
| IMNN Stock | USD 0.83 0.02 2.35% |
Below is the normalized historical share price chart for Imunon Inc extending back to July 24, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Imunon stands at 0.83, as last reported on the 21st of December, with the highest price reaching 0.89 and the lowest price hitting 0.81 during the day.
If you're considering investing in Imunon Stock, it is important to understand the factors that can impact its price. Imunon Inc holds Efficiency (Sharpe) Ratio of -0.0675, which attests that the entity had a -0.0675% return per unit of risk over the last 3 months. Imunon Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Imunon's Risk Adjusted Performance of (0.06), standard deviation of 3.86, and Market Risk Adjusted Performance of (0.30) to validate the risk estimate we provide.
At this time, Imunon's Total Stockholder Equity is very stable compared to the past year. As of the 21st of December 2024, Common Stock Shares Outstanding is likely to grow to about 9.5 M, while Common Stock is likely to drop about 89.3 K. . At this time, Imunon's Price Book Value Ratio is very stable compared to the past year. As of the 21st of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.01, while Price To Sales Ratio is likely to drop 21.07. Imunon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of March 1999 | 200 Day MA 1.1466 | 50 Day MA 0.8752 | Beta 2.134 |
Imunon |
Sharpe Ratio = -0.0675
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMNN |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Imunon is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imunon by adding Imunon to a well-diversified portfolio.
Price Book 1.5121 | Enterprise Value Ebitda 0.9097 | Price Sales 17.9405 | Shares Float 13.8 M | Wall Street Target Price 13.2 |
Imunon Main Headline on 20th of September 2024
Imunon Stock, Analyst Ratings, Price Targets, Forecasts - Be... by news.google.com
Imunon Stock, Analyst Ratings, Price Targets, Forecasts Benzinga
Imunon Valuation on September 20, 2024
It is possible to determine the worth of Imunon on a given historical date. On September 20, 2024 Imunon was worth 1.07 at the beginning of the trading date compared to the closed value of 1.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Imunon stock. Still, in general, we apply an absolute valuation method to find Imunon's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Imunon where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Imunon's related companies.
| Open | High | Low | Close | Volume | |
| 1.14 | 1.16 | 1.06 | 1.07 | 294,289 | |
09/20/2024 | 1.07 | 1.07 | 0.95 | 1.03 | 510,984 |
| 1.07 | 1.07 | 1.03 | 1.03 | 204,399 |
| Backtest Imunon | | | Imunon History | | | Imunon Valuation | Previous | Next |
Imunon Trading Date Momentum on September 20, 2024
| On September 23 2024 Imunon Inc was traded for 1.03 at the closing time. The top price for the day was 1.07 and the lowest listed price was 1.03 . The trading volume for the day was 204.4 K. The trading history from September 23, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.94% . |
Imunon Inc Fundamentals Correlations and Trends
By evaluating Imunon's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Imunon's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Imunon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Imunon Stock history
Imunon investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Imunon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Imunon Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Imunon stock prices may prove useful in developing a viable investing in Imunon
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9 M | 9.5 M | |
| Net Loss | -32.3 M | -33.9 M |
Imunon Quarterly Net Working Capital |
|
Imunon Stock Technical Analysis
Imunon technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Imunon Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Imunon Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Imunon December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Imunon stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Imunon shares will generate the highest return on investment. By undertsting and applying Imunon stock market strength indicators, traders can identify Imunon Inc entry and exit signals to maximize returns
Imunon Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Imunon's price direction in advance. Along with the technical and fundamental analysis of Imunon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Imunon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imunon Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Imunon. If investors know Imunon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Imunon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 0.014 | Return On Assets (0.67) | Return On Equity (1.48) |
The market value of Imunon Inc is measured differently than its book value, which is the value of Imunon that is recorded on the company's balance sheet. Investors also form their own opinion of Imunon's value that differs from its market value or its book value, called intrinsic value, which is Imunon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Imunon's market value can be influenced by many factors that don't directly affect Imunon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Imunon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imunon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Imunon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.